Selective Short-term Fertilization Combined with Early Rescue ICSI: An Optimal Strategy for Patients at High Risk for Fertilization Failure

Size: px
Start display at page:

Download "Selective Short-term Fertilization Combined with Early Rescue ICSI: An Optimal Strategy for Patients at High Risk for Fertilization Failure"

Transcription

1 Journal of Reproduction & Contraception doi: /j.issn Dec.; 25(4): Selective Short-term Fertilization Combined with Early Rescue ICSI: An Optimal Strategy for Patients at High Risk for Fertilization Failure Yu-ling HUANG 1,2*, Ai-hua WU 2*, Jian-qiao LIU 2 1. Center for Reproductive Medicine, the Third Affiliated Hospital of Guangzhou Medical University; Key Laboratory for Reproductive Medicine of Guangdong Province; Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou , China 2. Obstetrics and Gynecology Department, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou , China Objective To investigate clinical outcomes in patients who were at more precise criteria risks for fertilization failure and were treated with selective, short-term fertilization (oocytes and sperm co-incubated for 4 h) and early rescue intracytoplasmic sperm injection (ICSI). Methods A retrospective analysis was performed on women undergoing assisted reproductive technology (ART). They were assigned to 4 groups: short-term in vitro fertilization (short-term IVF, group A, n=217), regular IVF (oocytes and sperm coincubated overnight, group B, n=1 475), short-term IVF and early rescue ICSI (shortterm ICSI, group C, n=94), and regular ICSI (group D, n=237). Results In group A, 69.8% (217/311) achieved normal fertilization rates, and the complete fertilization failure rate (fertilization rate was 0%) was 12.9% (40/311). But all of the fertilization failure oocytes got rescue ICSI. In group B, the complete fertilization failure rate was 1.1% (19/1 692). The fertilization rate, 2 PN (pronucleus) rate, and 1 PN rate were significantly lower in group A than those in group B (70.9% vs 80.8%, 57.8% vs 66.3%, and 3.5% vs 6.2%, respectively). No significant differences were observed in clinical pregnancy rates and birth defect rates between groups A and B. The fertilization rates in groups C and D did not significantly differ (77.9% vs 76.2%), which was also true for birth defect rates. The clinical pregnancy rate of group C was higher than that of group D (51.2% vs 42.3%), but this difference was not significant (P). This work was supported by Science and Information Technology of Guangzhou (2012Y ) Corresponding author: Jian-qiao LIU; ljq88gz@qq.com *: These authors contributed equally to this work 207

2 Conclusion These results suggested that selective, short-term fertilization can result in effective outcomes for patients who were at high risk for fertilization failure. Key words: in vitro fertilization and embryo transfer (IVF-ET); short-term fertilization; early rescue intracytoplasmic sperm injections (ICSI); pregnancy Fertilization failure can occur in 3.52% 20% of patients who have been treated with in vitro fertilization and embryo transfer (IVF-ET) [1-4]. However, there is no effective indicator to precisely predict the chance of fertilization failure. In the event of failure, patients may have to surrender the cycle because there are no more embryos to transfer, which causes financial loss and psychological trauma. Intracytoplasmic sperm injections (ICSI) can be performed within h to rescue the fertilization failure, thereby potentially reducing the financial loss and providing the patients with reassurance. This remedial measure can increase fertilization rates by 30% 76% [5]. However, the pregnancy rates remain low because 1-day-old oocytes age rapidly and lose their embryo development potentials [6-8]. ICSI is not currently widely used because of the low associated pregnancy rates of the 24 h eggs. Some authors have used a half-icsi method (half-ivf and half-icsi) to avoid the complete failure of fertilization and achieved normal fertilization in a substantial number of patients. In fact, Plachot et al. and Wang et al. reported [9,10] that 67.2% and 63.6% of patients, respectively, achieved normal fertilization. However, the half-icsi method does not appear to be advantageous in patients who achieve fertilization via both IVF and ICSI because it increases the financial burden and the proportion of ICSI cases in assisted reproductive technology (ART), which is not in accordance with relevant Chinese policies. Currently, the success rates of ICSI and conventional IVF are similar. However, the long-term risks that are associated with ICSI [11] raise doubts regarding its ability to replace conventional IVF treatments, and more evidence is needed. A previous study assessing ICSI reported the presence of a second polar body (Pb2) in 78.3% of the eggs at 3 h after injection, and assessment diodes successfully predicted egg fertilization using specificity and sensitivity analyses during the first 3 h after injection [12]. A longer duration of fertilization has been associated with higher proportions of Pb2, and in fact, Suppinyopong et al. [13] observed that 84.4% of fertilized oocytes formed Pb2 at 6 h after ICSI. Additionally, Jin et al. [14] observed that 84.5% of M II oocytes formed Pb2 at 4 h after IVF, 93.3% of which were fertilized. The short co-incubation of the gametes has been demonstrated to reduce this time to 1 6 h, and even as short as 30 s, to achieve fertilization [15]. Preliminary studies in patients that have been treated with conventional IVF revealed that no oocytes contained the second polar bodies after the granulosa cells were stripped for 6 h, 208

3 but a timely rescue by ICSI was achieved [16]. This injection improved the fertilization, pregnancy, and implantation rates of early rescue ICSI at 4 h or 6 h after insemination compared with rescue ICSI at 22 h after insemination, which is after the oocytes have aged [14,16]. Previous studies have demonstrated [14,16] that removing the cumulus cells at 4 h or 6 h after insemination and combining early rescue ICSI is an efficient back-up option for unfertilized oocytes, and it may prevent the complete fertilization failure that is often observed with conventional IVF. In fact, some centers have adopted short-term fertilization for all patients (except ICSI) to prevent complete fertilization failure. The window of opportunity for polar body detection and cumulus cell removal in short-term fertilization is crucial for pronucleus formation, and therefore, its long-term safety has been questioned. Too much external stimulation may increase the risks of detrimental epigenetic events in the offspring. Moreover, conflicts with routine work schedules increase the workloads of the embryologists and the operating costs of the centers. Adopting short-term fertilization combined with rescue ICSI for patients who are at high risk for fertilization failure can circumvent the unnecessary use of ICSI and enable fertilization before the oocytes lose their developmental potential [14,17]. However, controversies over the standards that must be set for the prevention of these failures remain. Primary infertility, males with seminal thresholds, and unexplained infertility are all generally associated with high risks for fertilization failure [14,17], but primary infertility in women is controversial. To date (unpublished data), quite a few male patients have been observed to exhibit indicators for ICSI as reported by the World Health Organization (WHO) Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction (5th edition), including teratospermia rates 99%, sperm deformity index (SDI) 1.6, and acrosin<52 U/L. However, positive anti-sperm antibodies in seminal plasma (as detected using an immune bead assay) may allow for normal fertilization if the sperm motilities and densities are normal. Thus, these patients were selected as subjects in this study together with the other 2 aforementioned high-risk groups, and the resulting clinical effects, IVF failure rates, and ICSI proportions were observed at our reproductive center. Materials & Methods Patient selection and characteristics A total of patients were studied from July 2012 to April 2013 at the Assisted Reproductive Center of the Third Affiliated Hospital of Guangzhou Medical University. The female patients were years old, and >5 oocytes were obtained from each patient. Among them, 311 patients experienced the following characteristics: 1) primary infertility and male sperm densities ranging (5 15) 10 6 /ml with sperm motilities of (a+b) 10% 35%; 209

4 2) unexplained infertility; 3) normal sperm motilities and densities but one of the following: teratospermia rates 99%, SDI 1.6, acrosin<52 U/L, and positive anti-sperm antibodies in the seminal plasma (coated sperm>10% as shown by immune bead assay). A total of 217 patients (short-term IVF, group A) underwent normal fertilization, which was defined as 30% of mature oocytes showing 2 polar bodies (Pb), and 94 underwent early rescue ICSI (shortterm ICSI, group C). A total of patients who possessed IVF indicators without the aforementioned conditions were treated with regular overnight fertilization (regular IVF, group B). A total of 237 patients for the male factor infertility factors had regular ICSI (regular ICSI, group D), excluding the surgical sperm aspiration patients. All of these procedures were approved by the ethics committee of our hospital. All participants provided their written consent to participate in this study. Superovulation scheme A routine procedure of long-programmed ovarian stimulation was performed. On the 19th to 21st day of the last menstrual period, mg of Diphereline (triptorelin acetate for injection, IPSEN Co., France) was injected to down-regulate the hormones. On the 2nd 3rd day of menstruation, when the serum LH and E2 reached standard levels, Gonal-F (Serono Co., Switzerland) was injected to stimulate ovulation. When over 3 follicles were present with the diameter 18 mm, which could be observed by ultrasound inspection, U hcg (Livzon Co., China) was injected to promote follicular maturation. The oocytes were harvested and guided by transvaginal ultrasound h later. Sperm mixed agglutination surface antibody The sperm membrane surface antibody IgG was detected using a sperm membrane surface antibody IgG detection kit (Kang Biomedical Engineering Co., Shenzhen, China). When more than 10% of the sperm were coated, the mixed agglutination reaction (MRA) test was considered to be positive. Test for teratospermia rate The teratospermia rate was tested according to the WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction (5th edition). Modified Papanicolaou staining was used for the spermatozoa, which was suggested for sperm morphology analyses detection. IVF and Pb observation The oocytes were harvested and fertilized according to previously described methods [18]. Oocytes in group A were fertilized at h after hcg injection and co-incubated for 4 h. In group B, the fertilization time was h after hcg injection, and co-incubation was performed for h. Four hours after fertilization, the granulosa cells could be stripped to observe Pb2 in group A. Fertilization was identified as the appearance of two separate Pb or Pb2 in the dynamic observation. Normally, the 2 separate Pb were present in over 30% of 210

5 the mature oocytes within 6 h of fertilization. Otherwise, rescue ICSI was applied to the oocytes that lacked a Pb2. Available embryo evaluation We performed the standard evaluations at our center. The cleavage available embryos were transferred and frozen if cell counts of >5 could be obtained at h after oocyte harvest with cell fragments of 20%, and a ratio of maximal blastomeres to minimum blastomeres of <2. Embryo transfer and patient preparation The embryos were transferred at 72 h after oocyte harvest. The number of transferred embryos was decided according to the standards of the Ministry of Health and our center to lower the multiple pregnancy rate. For patients who were <38 years old, 2 embryos were transferred, and for those who were 38 years old or with 3 treatment cycles, 3 embryos were transferred. Progesterone or hcg was routinely used to support the corpus luteum. Serum hcg was tested to identify pregnancy at 14 d after transplantation. When the gestational sac and embryo bud were detected by ultrasound at 4 weeks after transplantation, the patient was diagnosed as pregnant. Statistical analysis The data are shown as mean standard deviation (x s). Student s t test and χ 2 test were used for the statistical analyses using the SPSS 17.0 software. P<0.05 was considered to be statistically significant. Results The basic information describing the patients in groups A and B was compared (Table 1). As shown in Table 1, the patients ages, BMI, mean duration of infertility, and basic E 2 and FSH levels did not significantly differ between the two groups. Primary infertility in group A was significantly higher than that in group B (64.1% vs 44.0%). These two groups also had significantly different unexplained infertility rates, male factor rates, and complex factor rates (P<0.05). The fertilization rates, the 2 PN rates, and the 1 PN rates of group A were significantly lower than those of group B (P<0.05). Notably, 3 PN rates were significantly higher than those of group B (P<0.05). Significant differences in the available embryo rates were also observed between the two groups (P<0.05) (Table 2). However, the rates of clinical pregnancies, miscarriages, ectopic pregnancies, live births, and birth defects were not significantly different (P). A total of 94 patients underwent rescue ICSI (group C) (Table 3), and all of them transfered their embryos from ICSI. Compared with the 237 regular ICSI patients (group D), 211

6 Table 1 Clinical data for the short-term IVF group (group A) and regular IVF group (group B) (x s, %) Indicator Short-term IVF Regular IVF P value No. of cycles (n) Age (year) BMI (kg/m 2 ) Mean duration of infertility (a) Primary infertility (%) Main cause of infertility Tubal disease (%) Endometriosis (%) Anovulation (%) Unexplained (%) Male factor (%) Complex (%) Basic hormone 64.1 (139/217) 24.9 (54/217) 5.5 (12/217) 2.3 (5/217) 11.5 (25/217) 22.1 (48/217) 33.7 (73/217) 44.0 (649/1 475) 65.5 (966/1 475) 3.6 (53/1 475) 5.6 (82/1 475) 2.7 (40/1 475) 2.3 (34/1 475) 20.3 (300/1 475) <0.05 E2 (pmol/l) FSH (U/L) Table 2 Clinical outcomes of the short-term IVF group (group A) and regular IVF group (group B) (x s, %) Indicator Short-term IVF Regular IVF P value n ET cycles (n) No. of oocytes retrieved (n) Fertilization (%) 1 PN rate (%) 2 PN rate (%) Polyspermy rate (%) Complete fertilization failure (%) Cleavage rate (%) Useful embryo rate (%) Useful oocyte rate (%) 70.9 (1 984 /2 797) 3.5 (99/2 797) 57.8 (1 618/2 797) 9.6 (267/2 797) 0.0 (0/217) 97.8 (1 942/1 984) 55.3 (1 097/1 984) 39.2 (1 097/2 797) 80.8 (15 280/18 909) 6.2 (1 173/18 909) 66.3 (12 547/18 909) 8.3 (1 560/18 909) 1.3 (19/1 475) 97.6 (14 916/15 280) 52.3 (7 994/15 280) 42.3 (7 994/18 909) <0.05 <0.05 Mean No. of embryos transferred (n) <0.05 Implantation rate (%) Clinical pregnancy rate (%) Multiple pregnancy rate (%) Miscarriage rate (%) Ectopic pregnancy rate (%) Live birth rate (%) 35.0 (143/408) 52.3 (103/197) 36.9 (38/103) 13.6 (14/103) 2.9 (3/103) 44.2 (87/197) 35.0 (918/2 618) 51.1 (667/1 306) 37.8 (252/667) 15.3 (102/667) 2.7 (18/667) 41.9 (547/1 306) Rate of birth defects ( ) 0.0 (0/126) 11.6 (9/775) no significant differences were observed in their ages, BMI, infertility duration and basic hormone levels. Notably, infertility as caused by the male factor in group D was higher than that in group C (P). The fertilization rates, the cleavage rates, the available embryo 212

7 Table 3 Clinical data for the rescue ICSI group (group C) and regular ICSI group (group D) (x s, %) Indicator Rescue ICSI Regular ICSI P value No. of cycles (n) Age (year) BMI (kg/m 2 ) Mean duration of infertility (a) Primary infertility (%) Main cause of infertility Tubal disease (%) Endometriosis (%) Anovulation (%) Unexplained (% ) Male factor (%) Complex (%) Basic hormone 78.7 (74/94) 12.8 (12/94) 1.1 (1/94) 3.2 (3/94) 5.3 (5/94) 42.6 (40/94) 35.0 (33/94) 69.6 (165/237) 6.3 (15/237) 2.1 (5/237) 1.3 (3/237) 1.3 (3/237) 59.5 (141/237) 29.5 (70/237) E2 (pmol/l) FSH (U/L) rates, the miscarriage rates, the ectopic pregnancy rates, the live birth rates, and the birth defect rates of groups C and D did not significantly differ (P) (Table 4). However, the Table 4 Clinical outcomes of the rescue ICSI group (group C) and regular ICSI group (group D) (x s, %) Indicator Rescue ICSI Regular ICSI P value n ET cycles (n) No. of oocytes retrieved (n) Comepletely rescue ICSI (%) No. of oocytes for rescue ICSI (n) Fertilization (%) 1 PN rate (%) 2 PN rate (%) Polyspermy rate (%) Cleavage rate (%) Useful embryo rate (%) Useful oocyte rate (%) 43.5 (40/92) (640/822) 4.5 (37/822) 66.4 (546/822) 7.0 (57/822) 96.9 (620/640) 53.9 (415/770) 50.5 (415/822) / / 76.2 (1 727/2 267) 3.0 (69/2 267) 71.3 (1 616/2 267) 1.9 (42/2 267) 97.6 (1 686/1 727) 55.0 (949/1 727) 41.9 (949/2 267) <0.05 Mean No. of embryos transferred (n) Clinical pregnancy rate (%) Implantation rate (%) Multiple pregnancy rate (%) Miscarriage rate (%) Ectopic pregnancy rate (%) Live birth rate (%) 51.2 (42/82) 35.1 (59/168) 40.5 (17/42) 11.9 (5/42) 0.0 (0/42) 45.1 (37/82) 42.3 (88/208) 27.0 (112/415) 27.3 (24/88) 11.4 (10/88) 2.3 (2/88) 36.5 (76/208) Rate of birth defects ( ) 19.2 (1/52) 10.0 (1/99) 213

8 multiple PN rate of group C was significantly higher than that of group D (P). The clinical pregnancy rate of group C was higher than that of group D, but this difference was not significant (P). In this study of short-term fertilization patients, 69.8% (217/311) achieved normal fertilization rates. To them the complete fertilization farlure rate (fertilization rate was 0%) was 12.9% (40/311) and part fertilization farlure rate (fertilization rate <30%) was 17.4 % (54/311). But all of the fertilization failure oocytes got rescue ICSI. To the regular IVF patients the complete fertilization failure rate was 1.1% (19/1 692). Discussion For short-term fertilization, the mechanical stimulation that is associated with the stripping of granulose cells may pose epigenetic risks to embryo development. Therefore, it is offered as a complementary option to ART patients. In this study, patients who were at high risk for fertilization failure were treated with short-term fertilization, and 69.8% (217/311) achieved normal fertilization rates. The complete fertilization failure rate in the IVF patients was 1.1% (19/1 692), which was much lower than the lowest rate of 3.52% that was previously reported [4]. The proportion of ICSI was 16.36% (331/2 023), which was also lower than the rate that was reported in a previous study of 19.97% [17]. The former criteria for short-term fertilization were primary infertility, unexplained infertility, and seminal threshold. We adopted more precise inclusion criteria as follows: 1) primary infertility, including males with a threshold of sperm motility and density; 2) unexplained infertility; and 3) normal sperm motility and density with only one of the following: a teratospermia rate of 99%, SDI 1.6, acrosin <52 U/L, and positive anti-sperm antibodies in the seminal plasma as detected by an immune bead assay. These new criteria did not expand the scope of short-term fertilization, but did help to avoid unnecessary short-term fertilization and decreased the workload at the center. Moreover, these new criteria decreased the complete fertilization failure rate and lowered the proportion of ICSI, which could aid in the optimization of IVF strategies. The fertilization and 2 PN rates of the short-term IVF group were significantly lower than those of the regular IVF group, which was not consistent with the lack of difference that was previously reported [14,17]. However, we selected high-risk patients for fertilization failure using more precise inclusion criteria, while previous studies did not use these criteria. However, the 3 PN rate was significantly higher in the short-term IVF group than in the regular group. This may have been due to the removal of the granulosa cells within 4 h after fertilization, which could have damaged the zona pellucida, which is a natural barrier that prevents polyspermy. Additionally, mechanical stripping could damage the microstructures of the oocytes and affect spindle bodies, for example, resulting in the abnormal formations of polar bodies [14]. Nevertheless, if granulosa cells are removed within 6 h, the polyspermy 214

9 problem is resolved [14,19]. However, for the rescue ICSI patients, the clinical pregnancy rate, the implantation rate, and the live birth rate were higher in those individuals who had their granulosa cells stripped within 6 h compared with those whose cells were stripped at 6 8 h or after over 8 h [20]. Considering the advantages and disadvantages, we considered 4 h after fertilization to be the best time for granulosa cell removal. The available embryo rate of the short-term IVF group was significantly higher than that of the regular IVF group, and the clinical pregnancy rate was slightly higher. Reducing the binding time of the egg and the sperm may improve the quality of the embryo [21] because fewer reactive oxygen species (ROS) would be generated from dead sperm, which would otherwise harden the zona pellucida and reduce embryo vitality. Additionally, this method may diminish the burden of the sperm for supplying nutrients to support embryo development. Stripping the granulosa cells of the oocyte-corona-cumulus complex could also eliminate the adverse effects of hormones on the embryo [22]. Increased estrogen has been suggested to directly influence the development and implantation of the embryo, and high levels of external estrogen may have direct toxic effects [23]. Short-term fertilization can avoid the aforementioned problems, increase the developmental potential of the embryo, and improve the pregnancy outcome. In this study, which is consistent with previous reports, the miscarriage rates, the ectopic pregnancy rates, the live birth rates, and the birth defect rates did not significantly differ, confirming the positive effects of short-term fertilization on pregnancy outcomes. Rescue ICSI is a complementary treatment for fertilization failure that can provide hope for patients who are at high risk. Late rescue ICSI, which is carried out within h after complete fertilization failure, has only been reported to achieve a pregnancy success rate of 9.7% [5] ; in fact, the aged egg may be experience increased aneuploidy rates [23,24]. Increased aneuploidy was a confounding factor in the aforementioned study because the failed eggs had high aneuploidy rates that were independent of the rescue timing. Furthermore, embryological diagnoses were used to determine that only 17% of the embryos were normal diploids before implantation [25], and the increased aneuploidy rates were not isolated to the embryos that were used for the late rescue ICSI. Nevertheless, the aging of the egg may impact the cellular biochemistry, molecules and microstructure, and the arrangement of the spindle body and chromosomes [5,26], leading to unpredictable abnormalities in imprinting genes [23]. Short-term fertilization combined with early rescue ICSI can remedy fertilization failure before the oocytes aging. This method can increase the pregnancy success rate by up to 44% [5], which is a satisfying outcome. Additionally, no significant difference was observed in the fertilization rate; however, the multiple PN rate of the rescue ICSI group was significantly higher than that of the regular ICSI group. Polyspermy may also occur when sperm enters the oocyte without achieving activation. Therefore, sperm could be 215

10 injected into an oocyte that was already penetrated by a sperm during IVF. The signs of fertilization (oocyte activation) are difficult to identify in some oocytes, particularly in those with fragmented polar bodies, which may be another reason for the elevated polyspermy rates. The avoidance of polyspermy may be difficult [20]. Nevertheless, the available embryo rates did not significantly differ between the two groups. Therefore, this study suggests that short-term fertilization in combination with early rescue ICSI is an optimal strategy for patients who are at high risk for fertilization failure. This strategy may maximize chances of pregnancy success and reduce treatment costs. Selective short-term fertilization can prevent unnecessary ICSI treatment for high-risk patients who undergo normal fertilization procedures. Early rescue ICSI before the oocytes aging can achieve a higher number of gametes with development potentials and result in more satisfactory pregnancy outcomes in individuals who are experiencing complete fertilization failure and low fertilization rates. This method may be translated into clinical practice. References 1. Staessen C, Camus M, Clasen K, et al. Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod, 1999, 14(10): Liu DY, Baker HW. Defective sperm-zona pellucida interaction: a major cause of failure of fertilization in clinical in-vitro fertilization. Hum Reprod, 2000, 15(3): Combelles CM, Morozumi K, Yanagimachi R, et al. Diagnosing cellular defects in an unexplained case of total fertilization failure. Hum Reprod, 2010, 25(7): Ming L, Liu P, Qiao J, et al. Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome. Reprod Biomed Online, 2012, 24(5): Beck-Fruchter R, Lavee M, Weiss A, et al. Rescue intracytoplasmic sperm injection: a systematic review. Fertil Steril, 2014, 101(3): Morton PC,Yoder CS, Tucker MJ, et al. Reinsemination by intracytoplasmic sperm injection of 1-day-old oocytes after complete conventional fertilization failure. Fertil Steril, 1997, 68(3): Yuzpe AA, Liu Z, Fluker MR. Rescue intracytoplasmic sperm injection (ICSI)-salvaging in vitro fertilization (IVF) cycles after total or near total fertilization failure. Fertil Steril, 2000, 73(6): Kuczyñski W, Dhont M, Grygoruk C, et al. Rescue ICSI of unfertilized oocytes after IVF. Hum Reprod, 2002, 17(9): Plachot M, Belaisch-Allart J, Mayenga JM, et al. Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility. Hum Reprod, 2002, 17(2): Wang YQ, Yang J, Xu WM. Indications and clinical outcomes of half-icsi in 99 cases. Zhonghua Nan Ke Xue (in Chinese), 2009, 15(9): Ludwig M, Katalinic A, Gross S, et al. Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples. J Med Genet, 2005, 42(4): Van den Bergh M, Bertrand E, Englert Y. Second polar body extrusion is highly predictive for oocyte 216

11 fertilization as soon as 3 hr after intracytoplasmic sperm injection (ICSI). J Assist Reprod Genet, 1995, 12 (4): Suppinyopong S, Choavaratana R, Karavakul C. Timing of second polar body extrusion and pronuclear formation after intracytoplasmic sperm injection (ICSI). J Med Assoc Thai, 2000, 83(5): Jin H, Shu Y, Dai S, et al. The value of second polar body detection 4 hours after insemination and early rescue ICSI in preventing complete fertilisation failure in patients with borderline semen. Reprod Fertil Dev, 2014, 26(2): Bungum M, Bungum L, Humaidan P. A prospective study, using sibling oocytes, examining the effect of 30 seconds versus 90 min gamete co-incubation in IVF. Hum Reprod, 2006, 21(2): Chen C, Kattera S. Rescue ICSI of oocytes that failed to extrude the second polar body 6 h post-insemination in conventional IVF. Hum Reprod, 2003, 18(10): Xiong S, Han W, Liu JX, et al. Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF. J Assist Reprod Genet, 2011, 28(12): Huang YL, Du HZ, Kang XJ, et al. Related factors of in vitro fertilization and embryo transfer patients with complete fertilization failure. J Reprod Contracep, 2013, 24(2): Lundqvist M, Johansson U, Lundkvist O, et al. Reducing the time of co-incubation of gametes in human invitro fertilization has no beneficial effects. Reprod Biomed Online, 2001, 3(1): Liu WW, Liu JX, Zhang XD, et al. Short co-incubation of gametes combined with early rescue ICSI: an optimal strategy for complete fertilization failure after IVF. Hum Fertil (Camb), 2014, 17(1): Dirnfeld M, Bider D, Koifman M, et al. Shortened exposure of oocytes to spermatozoa improves in-vitro fertilization outcome: a prospective, randomized, controlled study. Hum Reprod, 1999, 14(10): Kattera S, Chen C. Short coincubation of gametes in in vitro fertilization im proves implantation and pregnancy rates: a prospective, randomized, controlled study. Fertil Steril, 2003, 80(4): Valbuena D, Martin J, de Pablo JL, et al. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril, 2001, 76(5): Miao YL, Kikuchi K, Sun QY, et al. Oocyte aging: cellular and molecular changes, developmental potential and reversal possibility. Hum Reprod Update, 2009, 15(5): Fragouli E, Escalona A, Gutierrez-Mateo C, et al. Comparative genomic hybridization of oocytes and first polar bodies from young donors. Reprod Biomed Online, 2009, 19(2): Takahashi T, Igarashi H, Amita M, et al. Molecular mechanism of poor embryo development in postovulatory aged oocytes: mini review. J Obstet Gynaecol Res, 2013, 39(10): (Received on October 6, 2014) 217

12 Conference Information International Society for Magnetic Resonance in Medicine (ISMRM) Workshop on MRI in the Management of Breast Disease: Past, Present & Future February 12th to 15th California / San Francisco Obstetrics / Gynecology, Oncology, Other Specialties, Radiology / Imaging Contact: Melisa Martinez, Meetings Coordinator, ISMRM Phone: Fax: info@ismrm.org Website: Updates in Women s Health February 13th to 15th Colorado / Breckenridge Family Medicine, General Medicine, Internal Medicine, Obstetrics / Gynecology Contact: Medical Education Resources, Inc. Phone: or Fax: info@mer.org Website: 38th Annual Advanced Ultrasound Seminar: Ob / Gyn February 18th to 21st Florida / Lake Buena Vista Obstetrics / Gynecology, Radiology / Imaging Contact: American Institute of Ultrasound in Medicine Phone: Fax: Website: International Society for the Study of Women s Sexual Health (ISSWSH) Annual Meeting February 19th to 22nd Texas / Austin Obstetrics / Gynecology Contact: ISSWSH Executive Office Phone: Fax: info@isswsh.org Website: Fertility Control Club - Hormonal Contraception Methods: From Basic Research to Clinical Practice February 19th to 21st Spain / Barcelona Obstetrics / Gynecology Contact: FCC Conference Secretariat, Conference Secretariat, ComtecMed Phone: Fax: fertilityclub@comtecmed.com Website: 218

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

More information

Biology of fertility control. Higher Human Biology

Biology of fertility control. Higher Human Biology Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

Dr Manuela Toledo - Procedures in ART -

Dr Manuela Toledo - Procedures in ART - Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

(BMI)=18.0~24.9 kg/m 2 ;

(BMI)=18.0~24.9 kg/m 2 ; 33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their

More information

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

Study on Several Factors Involved in IVF-ET of Human Beings

Study on Several Factors Involved in IVF-ET of Human Beings Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,

More information

Information Booklet. Exploring the causes of infertility and treatment options.

Information Booklet. Exploring the causes of infertility and treatment options. Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole

More information

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles

Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles Reproductive BioMedicine Online (2012) 24, 148 152 www.sciencedirect.com www.rbmonline.com ARTICLE Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles Maria Goudakou

More information

WHY INVESTIGATE FOR INFERTILITY

WHY INVESTIGATE FOR INFERTILITY WHY INVESTIGATE FOR INFERTILITY Intrauterine Insemination 1 About this booklet This series of booklets has been developed and written with the support of leading fertility clinics across Australia, and

More information

Should ICSI be implemented during IVF to all advanced-age patients with non-male factor subfertility?

Should ICSI be implemented during IVF to all advanced-age patients with non-male factor subfertility? Farhi et al. Reproductive Biology and Endocrinology (2019) 17:30 https://doi.org/10.1186/s12958-019-0474-y RESEARCH Open Access Should ICSI be implemented during IVF to all advanced-age patients with non-male

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

Causes of Infertility and Treatment Options

Causes of Infertility and Treatment Options Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre

More information

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2 Welcome Your fertility treatment journey begins here Fertility treatment can be complicated Managing expectations, keeping track of medications and appointments, remembering all the information your physician

More information

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should

More information

Subfertility B Y A L I S O N, B E N A N D J O H N

Subfertility B Y A L I S O N, B E N A N D J O H N Subfertility B Y A L I S O N, B E N A N D J O H N Contents Definition Causes Male Female Hx & Ex Investigations Treatment Definition Failure to conceive after a year of frequent, unprotected communion.

More information

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions

More information

Use of in vitro maturation for fertility preservation

Use of in vitro maturation for fertility preservation Use of in vitro maturation for fertility preservation G. Arroyo Servei de Medicina de la Reproducció Departament d Obstetrícia, Ginecologia i Reproducció INSTITUT UNIVERSITARI DEXEUS MEDICAL STRATEGY TO

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF) DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde Human Reproduction vol.14 no.1 pp.65 69, 1999 Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure

More information

Adoption and Foster Care

Adoption and Foster Care GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Web Activity: Simulation Structures of the Female Reproductive System

Web Activity: Simulation Structures of the Female Reproductive System differentiate. The epididymis is a coiled tube found along the outer edge of the testis where the sperm mature. 3. Testosterone is a male sex hormone produced in the interstitial cells of the testes. It

More information

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt* FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization

More information

Lecture 14: Conception, Fertility, Early Fetal Loss. provera. Depo-provera. Early Fetal Loss. Implanon. Norplant. Nuva Ring.

Lecture 14: Conception, Fertility, Early Fetal Loss. provera. Depo-provera. Early Fetal Loss. Implanon. Norplant. Nuva Ring. Lecture 14: Conception, Fertility, Early Fetal Loss Birth Control (cont.) Conception What Influences Probability of Conception? Early Fetal Loss Infertility Fertility Enhancement Depo-provera provera Injectable

More information

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur?

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,

More information

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem? Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.

More information

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin

More information

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for

More information

2013 Sep.; 24(3):

2013 Sep.; 24(3): Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does

More information

Phases of the Ovarian Cycle

Phases of the Ovarian Cycle OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000

More information

(1.,, ) (2.,,, )

(1.,, ) (2.,,, ) 33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature

More information

Age and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine

Age and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine 1 Age and Fertility A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine INTRODUCTION Fertility changes with age. Both males and females become fertile in

More information

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

Fertility assessment and assisted conception

Fertility assessment and assisted conception Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.

More information

Sperm Surface Antibodies: IUI vs. IVF Treatment

Sperm Surface Antibodies: IUI vs. IVF Treatment Research Article Sperm Surface Antibodies: IUI vs. IVF Treatment Afaf Felemban MD*, Seham M. Hassonah MD, Najla Felimban KD, Hadeel Alkhelb MD, Samar Hassan MD, Fahad Alsalman MD Department of Obstetrics

More information

Original Article Correlation between morphological abnormalities in the human oocyte zona pellucida, fertilization failure and embryonic development

Original Article Correlation between morphological abnormalities in the human oocyte zona pellucida, fertilization failure and embryonic development Int J Clin Exp Med 2016;9(1):260-267 www.ijcem.com /ISSN:1940-5901/IJCEM0015149 Original Article Correlation between morphological abnormalities in the human oocyte, fertilization failure and embryonic

More information

Unexplained infertility Evidence based management

Unexplained infertility Evidence based management Unexplained infertility Evidence based management Dr Mark Hamilton Consultant Gynaecologist NHS Grampian/University of Aberdeen m.hamilton@abdn.ac.uk www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc

More information

The sperm HBA that has been developed as a commercial diagnostic kit for assessing sperm. Proceedings of Singapore Healthcare Volume 22 Number

The sperm HBA that has been developed as a commercial diagnostic kit for assessing sperm. Proceedings of Singapore Healthcare Volume 22 Number original article Relationship between Sperm Hyaluronan-binding Assay (HBA) Scores on Embryo Development, Fertilisation, and Pregnancy Rate in Patients Undergoing Intra-cytoplasmic Sperm Injection (ICSI)

More information

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Clinical Policy Committee

Clinical Policy Committee Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Information about. Egg donation. Tel. (UK): +44(0) Tel. (Spain):

Information about. Egg donation.  Tel. (UK): +44(0) Tel. (Spain): Information about Egg donation www.ginefiv.co.uk Tel. (UK): +44(0)203 129 34 19 Tel. (Spain): +34 91 788 80 70 Index This brochure contains the following information: Index About Ginefiv...3 Our Egg Donation

More information

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential

Cryotop Vitrification Affects Oocyte Quality and Embryo Developmental Potential Cronicon OPEN ACCESS Ling Jia*, Bo Xu*, Yu-sheng Liu and Xian-hong Tong Center for Reproductive Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, China *These authors contributed

More information

Patient Overview: Invitro Fertilisation

Patient Overview: Invitro Fertilisation Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

NEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION

NEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION NEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION PATIENT NAME DOB AGE PARTNER NAME DOB AGE STREET CITY

More information

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER

OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER Ho Sy Hung, Trinh Thi Thuy Hanoi Medical University, Thaibinh Medical University INTRODUCTION Infertility rate

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Reproductive Endocrinology & Infertility Glossary

Reproductive Endocrinology & Infertility Glossary Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and

More information

REPRODUCTION The diagram below shows a section through seminiferous tubules in a testis.

REPRODUCTION The diagram below shows a section through seminiferous tubules in a testis. 1. The diagram below shows a section through seminiferous tubules in a testis. Which cell produces testosterone? 2. A function of the interstitial cells in the testes is to produce A sperm B testosterone

More information

Liyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction

Liyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction doi:10.1111/jog.13305 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1037 1042, June 2017 Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of

More information

Clinical ICSI in the horse:

Clinical ICSI in the horse: Clinical ICSI in the horse: differences and similarities to human in an in vitro maturation-based system Katrin Hinrichs College of Veterinary Medicine & Biomedical Sciences Texas A&M University Standard

More information

Androgens Hormones that are produced by the testes of the male and in small amounts by the ovaries and adrenal glands of the female.

Androgens Hormones that are produced by the testes of the male and in small amounts by the ovaries and adrenal glands of the female. http://www.myfertility.ca/glossary.xhtml (February 27, 2015) Glossary Acrosome This is a membrane-bound cap-like structure found at the head of the sperm. It contains enzymes that are thought to help the

More information

Novel Technologies for Selecting the Best Sperm for IVF and ICSI

Novel Technologies for Selecting the Best Sperm for IVF and ICSI Novel Technologies for Selecting the Best Sperm for IVF and ICSI Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA Testing The Sperm Population NOW Sperm DNA testing Although we are

More information

Infertility. Thomas Lloyd and Samera Dean

Infertility. Thomas Lloyd and Samera Dean Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived

More information

Ivf day 6 estradiol level

Ivf day 6 estradiol level Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

Chapter 36 Active Reading Guide Reproduction and Development

Chapter 36 Active Reading Guide Reproduction and Development Name: AP Biology Mr. Croft Chapter 36 Active Reading Guide Reproduction and Development Section 1 1. Distinguish between sexual reproduction and asexual reproduction. 2. Which form of reproduction: a.

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile

More information

Reproductive Technology, Genetic Testing, and Gene Therapy

Reproductive Technology, Genetic Testing, and Gene Therapy Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples

More information

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).

OVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ;   adm.cgmh.org.tw). OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung

More information

Infertility: A Generalist s Perspective

Infertility: A Generalist s Perspective Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and

More information

IVF: PAST, PRESENT AND FUTURE

IVF: PAST, PRESENT AND FUTURE IVF: PAST, PRESENT AND FUTURE Mark Larman Chief Scientific Officer 1 HISTORY OF IVF IVF first achieved with rabbits in 1959 IVF with human gametes - pioneered by Robert Edwards and Patrick Steptoe during

More information

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner

More information

EFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION

EFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION Acta Medica Mediterranea, 2018, 34: 883 EFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION XUAN-CHENG MAI, LEI DING, YONG-FANG XU,

More information

Realizing dreams booklet.indd 1 5/20/ :26:52 AM

Realizing dreams booklet.indd 1 5/20/ :26:52 AM Realizing dreams. 18891booklet.indd 1 5/20/2010 11:26:52 AM The Journey To Parenthood The first Gator Baby was born in 1988 through the in vitro fertilization program at the University of Florida. Since

More information

Chen et al. Reproductive Biology and Endocrinology (2018) 16:36 https://doi.org/ /s z

Chen et al. Reproductive Biology and Endocrinology (2018) 16:36 https://doi.org/ /s z Chen et al. Reproductive Biology and Endocrinology (2018) 16:36 https://doi.org/10.1186/s12958-018-0352-z RESEARCH Open Access Pregnancy outcomes of PCOS overweight/ obese patients after controlled ovarian

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

Rejuvenation of Gamete Cells; Past, Present and Future

Rejuvenation of Gamete Cells; Past, Present and Future Rejuvenation of Gamete Cells; Past, Present and Future Denny Sakkas PhD Scientific Director, Boston IVF Waltham, MA, USA Conflict of Interest I have no conflict of interest related to this presentation.

More information

INFERTILITY. Services - Part 2

INFERTILITY. Services - Part 2 INFERTILITY Services - Part 2 1 Imprint Published in January, 2013 By Victory A.R.T. Laboratory Phils, Inc. These articles were compiled by in hopes of helping bring into light infertility questions and

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017 MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

10.7 The Reproductive Hormones

10.7 The Reproductive Hormones 10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid

More information

AP Biology Ch ANIMAL REPRODUCTION. Using only what you already know (you cannot look up anything) complete the chart below.

AP Biology Ch ANIMAL REPRODUCTION. Using only what you already know (you cannot look up anything) complete the chart below. AP Biology Ch. 46 - ANIMAL REPRODUCTION Using only what you already know (you cannot look up anything) complete the chart below. I. Overview of Animal Reproduction A. Both asexual and sexual reproduction

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas FAILED OOCYTE MATURATION A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas INTRODUCTION In our laboratory,we perform (X) IVF and (Y) ICSI per year with a success

More information

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes Human Reproduction Vol.22, No.7 pp. 1991 1995, 2007 Advance Access publication on May 18, 2007 doi:10.1093/humrep/dem124 Optimal ICSI timing after the first polar body extrusion in in vitro matured human

More information